Why BofA worries about Hims & Hers. Hims & Hers stock has been a mega-outperformer for investors, growing more than 600% over ...

Hims & Hers, a health and wellness platform, is set to introduce at-home lab testing capabilities through the acquisition of ...

Telehealth pioneer Hims & Hers Health (HIMS) stock is soaring, with a 12% gain in recent days and a whopping 176% in the last ...

Hims & Hers Health, Inc. is a dramatically undervalued company if your holding period can be measured in decades. Read more ...

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, ...

BofA raised the firm’s price target on Hims & Hers to $21 from $18 and keeps an Underperform rating on the shares. The firm increased Q4 ...

We recently published a list of 10 Stocks Stand Strong Amid Cautious Market Environment. In this article, we are going to ...

This is the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.

There are wonders of the visual world—this week, dive into the hidden beauty of the plants that keep us alive, the less ...

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

There are wonders of the visual world—this week, dive into the hidden beauty of the plants that keep us alive, the less ...